• 1. Holm KS, Morris DO, Gomez SM, et al. Eosinophilic dermatitis with edema in nine dogs, compared with eosinophilic cellulitis in humans. J Am Vet Med Assoc 1999;215:649653.

    • Search Google Scholar
    • Export Citation
  • 2. Mauldin EA, Palmeiro BS, Goldschmidt MH, et al. Comparison of clinical history and dermatologic findings in 29 dogs with severe eosinophilic dermatitis: a retrospective analysis. Vet Dermatol 2006;17:338347.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3. Giannoulopoulos GD, Farmaki R, Koutinas CK, et al. Eosinophilic dermatitis with edema (Wells'-like syndrome) possibly triggered by cooked fish in a dog. J Hell Vet Med Soc 2011;62:320326.

    • Search Google Scholar
    • Export Citation
  • 4. Long H, Zhang G, Wang L, et al. Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol 2016;50:189213.

  • 5. Luna LG. Manual of histologic staining methods of the armed forces institute of pathology. 3rd ed. New York: McGraw-Hill Book Co, 1968;111112.

    • Search Google Scholar
    • Export Citation
  • 6. Gomes P, Torres SM, Plager DA, et al. Comparison of three staining methods to identify eosinophils in formalin-fixed canine skin. Vet Dermatol 2013;24:323328.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239245.

  • 8. Olivry T & Hill PB. The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions. Vet Immunol Immunopathol 2001;81:305309.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. Sakaria SS, Ravi A, Swerlick R, et al. Wells' syndrome associated with ulcerative colitis: a case report and literature review. J Gastroenterol 2007;42:250252.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Utikal J, Peitsch WK, Kemmler N, et al. Bullous eosinophilic cellulitis associated with ulcerative colitis: effective treatment with sulfasalazine and glucocorticoids. Br J Dermatol 2007;156:764766.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11. Lin HL, Lin JN, Chen CW, et al. Eosinophilic cellulitis after honeybee sting. J Formos Med Assoc 2009;108:964966.

  • 12. Tsuda S, Tanaka K, Miyasato M, et al. Eosinophilic cellulitis (Wells' syndrome) associated with ascariasis. Acta Derm Venereol 1994;74:292294.

    • Search Google Scholar
    • Export Citation
  • 13. Bassukas ID, Gaitanis G, Zioga A, et al. Febrile “migrating” eosinophilic cellulitis with hepatosplenomegaly: adult toxocariasis—a case report. Cases J 2008;1:356.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Hurni MA, Gerbig AW, Braathen LR, et al. Toxocariasis and Wells' syndrome: a causal relationship? Dermatology 1997;195:325328.

  • 15. Eren M & Açikalin M. A case report of Wells' syndrome in a celiac patient. Turk J Gastroenterol 2010;21:172174.

  • 16. Nakazato S, Fujita Y, Hamade Y, et al. Wells' syndrome associated with chronic myeloid leukaemia. Acta Derm Venereol 2013;93:375376.

  • 17. Gambichler T, Othlinghaus N, Rotterdam S, et al. Impetiginized Wells' syndrome in a patient with chronic lymphocytic leukaemia. Clin Exp Dermatol 2009;34:274e275.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Spinelli M, Frigerio E, Cozzi A, et al. Bullous Wells' syndrome associated with non-Hodgkin's lymphocytic lymphoma. Acta Derm Venereol 2008;88:530531.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Rajpara A, Liolios A, Fraga G, et al. Recurrent paraneoplastic Wells' syndrome in a patient with metastatic renal cell cancer. Dermatol Online J 2014;20:14.

    • Search Google Scholar
    • Export Citation
  • 20. Hirsch K, Ludwig RJ, Wolter M, et al. Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma. J Dtsch Dermatol Ges 2005;3:530531.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Yin G & Xie Q. Systemic lupus erythematosus associated with Wells' syndrome. Rheumatol Int 2012;32:10871089.

  • 22. Heelan K, Ryan JF, Shear NH, et al. Wells syndrome (eosinophilic cellulitis): proposed diagnostic criteria and a literature review of the drug-induced variant. J Dermatol Case Rep 2013;7:113120.

    • Search Google Scholar
    • Export Citation
  • 23. Yagi H, Tokura Y, Matsushita K, et al. Wells' syndrome: a pathogenic role for circulating CD4+ CD7- T cells expressing interleukin-5 mRNA. Br J Dermatol 1997;136:918923.

    • Search Google Scholar
    • Export Citation
  • 24. España A, Sanz ML, Sola J, et al. Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 1999;140:127130.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Simon HU, Plötz S, Simon D, et al. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. Eur J Immunol 2003;33:834839.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. French LE, Shapiro M, Junkins-Hopkins JM, et al. Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alpha. J Am Acad Dermatol 2003;49:11701174.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Mansfield C. Pathophysiology of acute pancreatitis: potential application from experimental models and human medicine to dogs. J Vet Intern Med 2012;26:875887.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Pietruczuk M, Dabrowska MI, Wereszczynska-Siemiatkowska U, et al. Alteration of peripheral blood lymphocyte subsets in acute pancreatitis. World J Gastroenterol 2006;12:53445351.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. German AJ, Helps CR, Hall EJ, et al. Cytokine expression in mucosal biopsies from German Shepherd Dogs with small intestinal enteropathies. Dig Dis Sci 2000;45:717.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Peters IR, Helps CR, Calvert EL, et al. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. J Vet Intern Med 2005;19:644653.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Ferreli C, Pinna AL, Atzori L, et al. Eosinophilic cellulitis (Wells' syndrome): a new case description. J Eur Acad Dermatol Venereol 1999;13:4145.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. Falagas ME & Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005;142:4755.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33. Sinno H, Lacroix JP, Lee J, et al. Diagnosis and management of eosinophilic cellulitis (Wells' syndrome): a case series and literature review. Can J Plast Surg 2012;20:9197.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34. Chung CL & Cusack CA. Wells syndrome: an enigmatic and therapeutically challenging disease. J Drugs Dermatol 2006;5:908911.

  • 35. Aroni K, Aivaliotis M, Liossi A, et al. Eosinophilic cellulitis in a child successfully treated with cetirizine. Acta Derm Venereol 1999;79:332.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36. Verma P, Singal A & Sharma S. Idiopathic bullous eosinophilic cellulitis (Wells' syndrome) responsive to topical tacrolimus and antihistamine combination. Indian J Dermatol Venereol Leprol 2012;78:378380.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37. Hasala H, Janka-Junttila M, Moilanen E, et al. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 2007;28:582591.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38. Kanei A, Asano K, Kanai K, et al. Inhibitory action of levocetirizine on the production of eosinophil chemoattractants RANTES and eotaxin in vitro and in vivo. In Vivo 2014;28:657666.

    • Search Google Scholar
    • Export Citation
  • 39. Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002;32:11871192.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40. Sedgwick JB & Busse WW. Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival. Ann Allergy Asthma Immunol 1997;78:581585.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement

Clinical and histologic features of acute-onset erythroderma in dogs with gastrointestinal disease: 18 cases (2005–2015)

Christine L. CainDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Search for other papers by Christine L. Cain in
Current site
Google Scholar
PubMed
Close
 DVM
,
Charles W. Bradley IIDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Search for other papers by Charles W. Bradley II in
Current site
Google Scholar
PubMed
Close
 VMD
, and
Elizabeth A. MauldinDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Search for other papers by Elizabeth A. Mauldin in
Current site
Google Scholar
PubMed
Close
 DVM
View More View Less

Abstract

OBJECTIVE To describe the clinical and histologic features of acute erythroderma in dogs with gastrointestinal disease.

DESIGN Retrospective case series.

ANIMALS 18 dogs with erythroderma and gastrointestinal disease.

PROCEDURES Medical records and biopsy specimens were reviewed. Information collected from medical records included signalment, clinical signs, physical examination and diagnostic test results, treatment, and outcome. The Naranjo algorithm was used to estimate the probability of an adverse drug reaction for each dog.

RESULTS All dogs had an acute onset of erythematous macules or generalized erythroderma. Histologic features of skin biopsy specimens had 3 patterns representing a progressive spectrum of inflammation. Most dogs had vomiting (n = 17) and hematochezia (10). Signs of gastrointestinal disease became evident before, after, or concurrent with the onset of skin lesions in 10, 3, and 5 dogs, respectively. Inflammatory bowel disease, pancreatitis, and adverse food reaction were diagnosed in 5, 3, and 3 dogs, respectively. The cause of the gastrointestinal signs was not identified for 8 dogs. Eight dogs had a Naranjo score consistent with a possible adverse drug reaction. Treatment of skin lesions included drug withdrawal (n = 15), antihistamines (16), and corticosteroids (14). Signs of gastrointestinal disease and skin lesions resolved at a mean of 4.6 days and 20.8 days, respectively, after onset.

CONCLUSIONS AND CLINICAL RELEVANCE Results indicated acute erythroderma may be associated with > 1 gastrointestinal disease or an adverse drug reaction in some dogs. Recognition of the clinical and histologic features of this syndrome is essential for accurate diagnosis.

Abstract

OBJECTIVE To describe the clinical and histologic features of acute erythroderma in dogs with gastrointestinal disease.

DESIGN Retrospective case series.

ANIMALS 18 dogs with erythroderma and gastrointestinal disease.

PROCEDURES Medical records and biopsy specimens were reviewed. Information collected from medical records included signalment, clinical signs, physical examination and diagnostic test results, treatment, and outcome. The Naranjo algorithm was used to estimate the probability of an adverse drug reaction for each dog.

RESULTS All dogs had an acute onset of erythematous macules or generalized erythroderma. Histologic features of skin biopsy specimens had 3 patterns representing a progressive spectrum of inflammation. Most dogs had vomiting (n = 17) and hematochezia (10). Signs of gastrointestinal disease became evident before, after, or concurrent with the onset of skin lesions in 10, 3, and 5 dogs, respectively. Inflammatory bowel disease, pancreatitis, and adverse food reaction were diagnosed in 5, 3, and 3 dogs, respectively. The cause of the gastrointestinal signs was not identified for 8 dogs. Eight dogs had a Naranjo score consistent with a possible adverse drug reaction. Treatment of skin lesions included drug withdrawal (n = 15), antihistamines (16), and corticosteroids (14). Signs of gastrointestinal disease and skin lesions resolved at a mean of 4.6 days and 20.8 days, respectively, after onset.

CONCLUSIONS AND CLINICAL RELEVANCE Results indicated acute erythroderma may be associated with > 1 gastrointestinal disease or an adverse drug reaction in some dogs. Recognition of the clinical and histologic features of this syndrome is essential for accurate diagnosis.

Contributor Notes

Address correspondence to Dr. Cain (ccain@vet.upenn.edu).